Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-11-30

FDA Approved: ONDANSETRON — Original Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approval notice for a generic ondansetron hydrochloride product (ondansetron) by Taro Pharmaceuticals U.S.A., Inc. under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

ORIG AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)